The Insulin Cap That Changed Everything
The single biggest recent change for people with diabetes is the $35 monthly cap on covered insulin. Under current rules, a one-month supply of each covered insulin product costs no more than $35 — with no deductible applied first — whether you get it through a Part D drug plan or a Medicare Advantage plan with drug coverage. For someone who used to pay hundreds a month in the coverage gap, this is life-changing money.
The cap applies per insulin product, and it covers both pharmacy-dispensed insulin and, separately, insulin used with a traditional pump (which is covered under Part B as durable medical equipment). If you're paying more than $35 for a covered insulin, something is set up wrong — and that's worth a phone call to fix.
Which Part Covers What
Diabetes care is split across Medicare's parts in ways that surprise people, because the same category of item can land under Part B or Part D depending on how it's used.
- Part B: blood sugar monitors, test strips, lancets, continuous glucose monitors (CGMs) and their supplies, insulin pumps and the insulin used in them, therapeutic shoes for diabetic foot conditions, and diabetes self-management training
- Part B also covers preventive screenings and a set number of nutrition therapy visits with a referral
- Part D: injectable and inhaled insulin not used with a pump, plus most oral diabetes medications and related supplies like syringes and needles
- The $35 insulin cap applies under both Part B and Part D coverage paths
Where the Costs Still Add Up
Even with generous coverage, diabetes has cost corners worth planning around. Under Original Medicare, Part B items like CGMs and pump supplies carry the standard 20% coinsurance with no annual cap — which is exactly the kind of ongoing, predictable expense a Medicare Supplement is designed to absorb. Newer, brand-name oral medications can sit on higher formulary tiers, so the plan's drug formulary matters enormously when you take more than insulin.
The other gap is choice of plan. A Medicare Advantage plan's network and prior-authorization rules can affect access to a specific CGM brand or an endocrinologist; a standalone Part D plan's formulary decides your medication costs. Neither is universally better — it depends entirely on your exact prescriptions and doctors, which is why the drug-by-drug comparison matters more for people with diabetes than almost anyone.
Getting It Set Up Right
The move that saves the most money is boring: list every diabetes-related medication and supply you use by name, then check them against the plans available in your county each fall. A CGM that's covered smoothly under one plan can require a fight under another; an insulin that's $35 on one formulary might need a formulary exception on the next. The official Medicare Plan Finder shows this, and we run the comparison for clients at no cost.
If your diabetes costs jumped this year, or a pharmacy quoted you far more than $35 for insulin, don't assume it's just how it is — call us. Getting the coverage set up correctly is often the difference between a manageable condition and a monthly budget problem, and it's exactly the kind of thing a fifteen-minute review can fix.
Free Consultation
Have Questions About Your Situation?
Every Medicare situation is different. Our licensed agents in Wyoming, Utah, Nevada and Idaho provide personalized guidance at no cost to you — no pressure, no obligation.